What Researchers Did
Researchers compared two radiotherapy schedules in patients with advanced head and neck cancer to see if using fewer, larger treatment doses worked as well as the standard, more gradual schedule.
What They Found
This randomized controlled trial of 98 matched patient pairs compared 10 radiation treatments given over 22 days against 30 treatments given over 42 days, using the same total radiation dose in both groups. Mucosal (mouth and throat lining) reactions were more severe in the 10-fraction group, while skin reactions were more severe in the 30-fraction group. The study found no difference between the two schedules in survival, local tumour control, or late tissue damage. Based on these results, the authors suggest it may be reasonable to use a small number of large fractions in future clinical trials, including ones that test hyperbaric oxygen or similar radiation-sensitizing agents alongside radiotherapy.
What This Means for Canadian Patients
This abstract does not report on hyperbaric oxygen therapy itself; hyperbaric oxygen is mentioned only as a possible factor in future trial designs, not as a treatment tested in this study. What it does address is radiotherapy scheduling: for patients with a poor prognosis, a shorter, more intensive course of radiation appeared to produce similar survival and tumour-control outcomes to a longer course, though the pattern of side effects differed between the two schedules.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a 1978 trial in a poor-prognosis patient population with no reported blinding, and it compared only two specific fractionation schedules without directly testing hyperbaric oxygen or sensitizer use.